Health Condition 1: null- Facial photodamage
Conditions
Interventions
Intervention1: Vitamin C 15 % w/w: To apply 7 drops on the face once a day in morning
Control Intervention1: NIL: NIL
Sponsors
Cipla Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1.Subjects willing to give written informed consent. 2.Subjects of either sex above 18 years of age. 3.Subjects with diagnosis of early to moderate photodamage 4.In the opinion of the investigator, able to comply with the requirements of the protocol.
Exclusion criteria
Exclusion criteria: 1.Subjects with hypersensitivity to study drug or any of it?s excipients of its formulation. 2.Judged by Investigator to be inappropriate as subjects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean change in Global clinical score for photodamageTimepoint: At week 4, 8 and 12 from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Mean change in Patients self assessmentTimepoint: At week 4, 8 and 12 from baseline;2. Change in photographic assessmentTimepoint: At week 12 from baseline;3. Skin tolerability will be notedTimepoint: At week 12 from baseline;4. Incidence and nature of adverse eventsTimepoint: At week 12 from baseline;5. Incidence of drug related adverse reactionsTimepoint: At week 12 from baseline | — |
Countries
India
Contacts
Public ContactDr Maya Vedamurthy
Outcome results
None listed